Regentis Biomaterials (RGNT) Long-Term Deferred Tax (2024 - 2025)
Regentis Biomaterials (RGNT) posted quarterly Long-Term Deferred Tax of $48.3 million for Q4 2025, up 24.04% year-over-year from $38.9 million in Q4 2024, and up 24.04% quarter-over-quarter from $38.9 million in Q4 2024.
Regentis Biomaterials (RGNT) Long-Term Deferred Tax (2024 - 2025) Analysis & Trends
Regentis Biomaterials (RGNT) has reported Long-Term Deferred Tax for 2 consecutive years, with $48.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Long-Term Deferred Tax rose 24.04% year-over-year to $48.3 million; the TTM figure through Dec 2025 stood at $48.3 million (up 24.04% YoY), while the FY2025 annual figure was $48.3 million, up 24.04% from the prior year.
- Long-Term Deferred Tax rose to $48.3 million in Q4 2025 per RGNT's latest filing, from $38.9 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $48.3 million in Q4 2025 and bottomed at $38.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Regentis Biomaterials | 1.21 Mn | -6.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48.30 Mn |
| Dec 31, 2024 | 38.94 Mn |